The table below shows Mirum Pharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$159.88M
$133.01M
$127.78M
$111.58M
$90.38M
$77.88M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
MIRM annual revenue (10-K history)
Mirum Pharmaceuticals, Inc. reported annual revenue of $521.31M for fiscal year 2025. That is up 54.7% from $336.89M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
